181 related articles for article (PubMed ID: 4609056)
1. Controlled clinical evaluation of a new anorectic agent in obese adults.
Elmaleh MK; Miller J
Pa Med; 1974 Sep; 77(9):46-50. PubMed ID: 4609056
[No Abstract] [Full Text] [Related]
2. Evaluation of a new anorexic agent in adolescence.
Bauta HP
Conn Med; 1974 Sep; 38(9):460-3. PubMed ID: 4606529
[No Abstract] [Full Text] [Related]
3. A new anorexiant. Clinical evaluation.
Smith DE
Rocky Mt Med J; 1974 Jan; 71(1):41-4. PubMed ID: 4131377
[No Abstract] [Full Text] [Related]
4. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
Defelice EA; Chaykin LB; Cohen A
Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
[No Abstract] [Full Text] [Related]
5. A double blind controlled trial of a new anorectic agent AN448.
Woodhouse SP; Nye ER; Anderson K; Rawlings J
N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
[TBL] [Abstract][Full Text] [Related]
6. [L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].
González Barranco J; Rull JA; Lozano Castañeda O
Prensa Med Mex; 1974; 39(5-6):298-9. PubMed ID: 4612507
[No Abstract] [Full Text] [Related]
7. Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
De Felice EA; Bronstein S; Cohen A
Curr Ther Res Clin Exp; 1969 May; 11(5):256-62. PubMed ID: 4977396
[No Abstract] [Full Text] [Related]
8. Obesity-depression: clinical evaluation with a new anorexigenic agent.
Kornhaber A
Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838
[No Abstract] [Full Text] [Related]
9. [Hypolipidemic effects of a new anorectic agent AN 448].
Dolecek R; Závada M
Cas Lek Cesk; 1973 Feb; 112(5):144-6. PubMed ID: 4685956
[No Abstract] [Full Text] [Related]
10. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
Dolecek R
Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197
[No Abstract] [Full Text] [Related]
11. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
Bienert HR; Uberla K
Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
[No Abstract] [Full Text] [Related]
12. Controlled trial of a new anorectic drug in the treatment of obesity.
Silverstone JT; Solomon T; Ross M; Kelly T
Br J Clin Pract; 1967 Jul; 21(7):337-9. PubMed ID: 4859981
[No Abstract] [Full Text] [Related]
13. Diethylpropion hydrochloride: an effective appetite suppressant.
Bolding OT
Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
[No Abstract] [Full Text] [Related]
14. A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients.
Thorpe PC; Isaac PF; Rodgers J
Curr Ther Res Clin Exp; 1975 Feb; 17(2):149-55. PubMed ID: 803428
[No Abstract] [Full Text] [Related]
15. Clinical evaluation of the anorexic activity and safety of 42-548 in children. Report of a clinical trial.
Sharma RK; Collipp PJ; Rezvani I; Strimas J; Maddaiah VT; Rezvani E
Clin Pediatr (Phila); 1973 Mar; 12(3):145-9. PubMed ID: 4573674
[No Abstract] [Full Text] [Related]
16. Two new appetite suppressants.
Med Lett Drugs Ther; 1974 Jun; 16(13):54. PubMed ID: 4842602
[No Abstract] [Full Text] [Related]
17. Comparison of a new anorectic agent AN 448 with fenfluramine in the treatment of refractory obesity.
Goldrick RB; Nestel PJ; Havenstein N
Med J Aust; 1974 Jun; 1(22):882-5. PubMed ID: 4604249
[No Abstract] [Full Text] [Related]
18. [Clinically controlled trial of Perphoxene].
Barbey JD
Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1242-6. PubMed ID: 4937701
[No Abstract] [Full Text] [Related]
19. Double-blind trial of anorectic agents.
Sproule BC
Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
[No Abstract] [Full Text] [Related]
20. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.
Feldman HS
J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
